Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/6/26 16:57 | 3/4/26 | BBIO | Health | Drug | Pharmaceutical Preparations | Ellis Andrea | CA | D | 1 | S.d | -4,211 | 64.87 | 0 | -65 | 19 | D | ||||||||||||||||
3/3/26 16:17 | 2/27/26 | BBIO | Health | Drug | Pharmaceutical Preparations | Valantine Hannah | CA | D | 1 | S.d | -1,718 | 67.41 | 0 | -25 | 8 | D | ||||||||||||||||
2/27/26 16:11 | 2/26/26 | BBIO | Health | Drug | Pharmaceutical Preparations | Apuli Maricel | CA | O | Chief Ac | 2 | S | -170 | 67.69 | 0 | -3 | 124 | D | |||||||||||||||
2/23/26 16:32 | 2/19/26 | BBIO | Health | Drug | Pharmaceutical Preparations | Kumar Neil | CA | DO | CEO | 4 | S.dm | -16,034 | 73.53 | 0 | -218 | 5,543 | D | |||||||||||||||
2/18/26 18:36 | 2/17/26 | BBIO | Health | Drug | Pharmaceutical Preparations | Trimarchi Thomas | CA | O | P,CFO | 1 | S | -1,016 | 74.72 | 0 | -14 | 337 | D | |||||||||||||||
2/18/26 18:34 | 2/17/26 | BBIO | Health | Drug | Pharmaceutical Preparations | Scott Randal W. | CA | D | 1 | S.d | -755 | 75.46 | 0 | -10 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |